Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
AngioDynamics (ANGO)
NASDAQ:ANGO
Holding ANGO?
Track your performance easily
ANGO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$5.26 - $9.58
Previous Close$8.89
Volume64.22K
Average Volume (3M)593.78K
Market Cap
$354.74M
Enterprise Value$306.23M
Total Cash (Recent Filing)$55.01M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.29
Next Earnings
Jan 08, 2025EPS Estimate
-$0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-6.04
Shares Outstanding40,634,249
10 Day Avg. Volume925,286
30 Day Avg. Volume593,776
Standard Deviation0.14
R-Squared0.07
Alpha-0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)1.84
Price to Sales (P/S)1.23
Price to Cash Flow (P/CF)-5.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.05
Enterprise Value/Gross Profit1.98
Enterprise Value/Ebitda-3.11
Forecast
1Y Price Target
$13.00Price Target Upside48.91% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
AngioDynamics News
PremiumCompany Announcements
AngioDynamics Shareholder Approvals and Director Elections
Bulls Say, Bears Say
Bulls Say
Clinical Study SuccessThe company's pivotal PRESERVE clinical study showed 84% of men were free from in-field, clinically significant disease at 12 months post-procedure.
Market ExpansionThe FDA clearance should enable the company to expand the commercial footprint of NanoKnife, which could help drive the company’s Med Tech sales growth.
Regulatory ApprovalFDA clearance for NanoKnife prostate received, allowing AngioDynamics to market its clinical data to both urologists and potential patients.
Bears Say
Cash FlowThe stock reaction is driven by the seasonally high cash burn.
Future ProspectsNanoKnife has the most catalysts ahead, but the impact of those may not come until late FY25 or early FY26.
RevenueThe stock reaction is driven by missing the consensus revenue estimate.
---
Ownership Overview
4.15% Insiders
17.03% Mutual Funds
26.04% Other Institutional Investors
40.66% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
ANGO FAQ
What was AngioDynamics’s price range in the past 12 months?
AngioDynamics lowest stock price was $5.26 and its highest was $9.58 in the past 12 months.
What is AngioDynamics’s market cap?
Currently, no data Available
When is AngioDynamics’s upcoming earnings report date?
AngioDynamics’s upcoming earnings report date is Jan 08, 2025 which is in 16 days.
How were AngioDynamics’s earnings last quarter?
AngioDynamics released its earnings results on Oct 03, 2024. The company reported -$0.11 earnings per share for the quarter, beating the consensus estimate of -$0.147 by $0.037.
Is AngioDynamics overvalued?
According to Wall Street analysts AngioDynamics’s price is currently Undervalued.
Does AngioDynamics pay dividends?
AngioDynamics does not currently pay dividends.
What is AngioDynamics’s EPS estimate?
AngioDynamics’s EPS estimate is -$0.11.
How many shares outstanding does AngioDynamics have?
AngioDynamics has 40,634,250 shares outstanding.
What happened to AngioDynamics’s price movement after its last earnings report?
AngioDynamics reported an EPS of -$0.11 in its last earnings report, beating expectations of -$0.147. Following the earnings report the stock price went down -16.732%.
Which hedge fund is a major shareholder of AngioDynamics?
Among the largest hedge funds holding AngioDynamics’s share is Royce & Associates LLC. It holds AngioDynamics’s shares valued at 8M.
---
AngioDynamics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$13.00 (48.91% Upside)
$13.00 (48.91% Upside)
Blogger Sentiment
Bullish
ANGO Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 374.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $135.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 4.7%
Last 30 Days ▼ 6.0%
Last 30 Days ▼ 6.0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
18.06%
12-Months-Change
Fundamentals
Return on Equity
-77.85%
Trailing 12-Months
Asset Growth
-40.55%
Trailing 12-Months
Company Description
AngioDynamics
AngioDynamics, Inc. engages in the development, manufacture, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. It offers ablation systems, fluid management systems, vascular access, angiographic, drainage. thrombolytic, and venous products. The company was founded by Eamonn P. Hobbs in 1988 and is headquartered in Latham, NY.
---
ANGO Company Deck
---
ANGO Earnings Call
Q1 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a balanced picture with strong growth in the Med Tech segment, particularly from Auryon and AlphaVac, and progress towards profitability. However, challenges remain in the Med Device segment and cash utilization was significant.Read More>---
ANGO Stock 12 Month Forecast
Average Price Target
$13.00
▲(48.91% Upside)
Technical Analysis
Best Analysts Covering ANGO
1 Year
1 Year Success Rate
9/11 ratings generated profit
1 Year Average Return
+19.99%
reiterated a buy rating 14 days ago
Copying Yi Chen's trades and holding each position for 1 Year would result in 81.82% of your transactions generating a profit, with an average return of +19.99% per trade.
---